Greenwich LifeSciences, Inc.
US ˙ NasdaqCM ˙ US3968791083

SecurityGLSI / Greenwich LifeSciences, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership29,827 shares
Latest Disclosed Value $ 716,445
Morgan Stanley reports 13.07% increase in ownership of GLSI / Greenwich LifeSciences, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 29,827 shares of Greenwich LifeSciences, Inc. (US:GLSI) valued at $716,445 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 26,379 shares of Greenwich LifeSciences, Inc.. This represents a change in shares of 13.07% during the quarter. The current value of the position is $706,005 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GREENWICH LIFESCIENCES COM 396879108 29,827 3,448 13.07 716 29.24 0.0000
2026-05-27 2025-12-31 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 26,379 17,658 202.48 554 544.19 0.0000
2026-02-13 2025-12-31 13F GREENWICH LIFESCIENCES COM 396879108 26,379 17,658 554 0.0000
2026-05-27 2025-09-30 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 8,721 -3,045 -25.88 87 -18.87 0.0000
2025-11-14 2025-09-30 13F GREENWICH LIFESCIENCES COM 396879108 8,721 -3,045 87 0.0000
2025-08-15 2025-06-30 13F GREENWICH LIFESCIENCES COM 396879108 11,766 2,219 23.24 107 16.48 0.0000
2025-05-15 2025-03-31 13F GREENWICH LIFESCIENCES COM 396879108 9,547 -4,227 -30.69 91 -40.91 0.0000
2025-05-15 2024-12-31 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 13,774 -3,257 -19.12 155 -36.89 0.0000
2025-02-14 2024-12-31 13F GREENWICH LIFESCIENCES COM 396879108 13,774 -3,257 155 0.0000
2025-05-14 2024-09-30 13F/A-2 GREENWICH LIFESCIENCES COM 396879108 17,031 9,978 141.47 245 101.65 0.0000
2025-02-14 2024-09-30 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 17,031 9,978 245 0.0000
2024-11-14 2024-09-30 13F GREENWICH LIFESCIENCES COM 396879108 17,031 9,978 245 0.0000
2025-05-14 2024-06-30 13F/A-2 GREENWICH LIFESCIENCES COM 396879108 7,053 823 13.21 122 -2.42 0.0000
2024-10-17 2024-06-30 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 7,053 823 122 0.0000
2024-08-14 2024-06-30 13F GREENWICH LIFESCIENCES COM 396879108 7,053 823 122 0.0000
2024-10-17 2024-03-31 13F/A-2 GREENWICH LIFESCIENCES COM 396879108 6,230 5,950 2,125.00 124 6,100.00 0.0000
2024-08-16 2024-03-31 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 6,230 5,950 124 0.0000
2024-05-15 2024-03-31 13F GREENWICH LIFESCIENCES COM 396879108 6,230 5,950 124 0.0000
2024-08-16 2023-12-31 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 280 0 0.00 3 0.00 0.0000
2024-02-13 2023-12-31 13F GREENWICH LIFESCIENCES COM 396879108 280 0 3 0.0000
2023-11-15 2023-09-30 13F GREENWICH LIFESCIENCES COM 396879108 280 -477 -63.01 2 -71.43 0.0000
2023-08-14 2023-06-30 13F GREENWICH LIFESCIENCES COM 396879108 757 -6,366 -89.37 7 -92.86 0.0000
2023-05-15 2023-03-31 13F GREENWICH LIFESCIENCES COM 396879108 7,123 -1,600 -18.34 98 -25.76 0.0000
2023-02-14 2022-12-31 13F GREENWICH LIFESCIENCES COM 396879108 8,723 -26,512 -75.24 133 -58.88 0.0000
2022-11-14 2022-09-30 13F GREENWICH LIFESCIENCES COM 396879108 35,235 -37,955 -51.86 321 -48.14 0.0000
2022-10-27 2022-06-30 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 73,190 51,483 237.17 619 45.31 0.0001
2022-08-15 2022-06-30 13F GREENWICH LIFESCIENCES COM 396879108 73,190 51,483 619 0.0001
2022-10-27 2022-03-31 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 21,707 -14,451 -39.97 426 -51.54 0.0001
2022-05-13 2022-03-31 13F GREENWICH LIFESCIENCES COM 396879108 21,707 -14,451 426 0.0001
2022-02-14 2021-12-31 13F GREENWICH LIFESCIENCES COM 396879108 36,158 35,461 5,087.66 879 3,155.56 0.0001
2021-11-15 2021-09-30 13F GREENWICH LIFESCIENCES COM 396879108 697 -7,704 -91.70 27 -92.86 0.0000
2021-08-23 2021-06-30 13F/A-1 GREENWICH LIFESCIENCES COM 396879108 8,401 3,779 81.76 378 139.24 0.0000
2021-08-16 2021-06-30 13F GREENWICH LIFESCIENCES COM 396879108 8,401 3,779 378 0.0000
2021-05-17 2021-03-31 13F GREENWICH LIFESCIENCES COM 396879108 4,622 819 21.54 158 14.49 0.0000
2021-02-16 2020-12-31 13F GREENWICH LIFESCIENCES COM 396879108 3,803 3,803 138 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.